Back to search

Democritus University of Thrace (DUTH)

Μελέτη των υποδοχέων διαφόρων ορμονών του υποθαλάμου σε καρκινοπαθείς

Abstract

dc:description

Introduction: The hypophysiotropic hormones, CRH and GHRH, secreted by the hypothalamus, reach, via the portal circulation, to the cells of the anterior pituitary. Additionally, some forms of cancer were associated with ectopic secretion of these hormones.Purpose: The purpose of this study was to detect the expression of CRH and GHRH receptors in breast cancer using immunohistochemistry and RT-PCR, to quantify the levels of gene expression using real time RT-PCR and to correlate the results with the histo/clinicopathological characteristics of the patients, their clinical course and their survival.Material: Thirty-three women (aged=60.2±13.2 years, ΒΜΙ=28.2±4.6 kg/m2) with breast cancer who underwent mastectomy in Theagenio Cancer Hospital were included in the study. The maximum diameter of the tumor was> 2 cm in 61% of the patients and <2 cm in the remaining 39%. Distant metastases at the time of diagnosis were found in 6.1% of the patients, whereas 60.6% of the rest of the patients showed lymph node metastases. During follow-up, which lasted from 24 to 68 months, the percentage of recurrent disease was 12.5%. At the end of the study, 81% of patients were free of disease, 13% were still ill and 6% were dead. Two biopsies were taken from each patient, one from the cancerous tissue and another one from the adjacent normal tissue. The results were compared.Method: Gene expression levels were evaluated by real-time PCR following reverse transcription of total RNA extracts. Histological mapping of receptor expression was done by immunohistochemistry, using receptor type selective antisera. Results: The receptors CRH-R1, CRH-R2a, SV1 and pGHRH-R were detected in 16.7%, 33.3%, 37% and 50%, respectively, of malignant biopsies and in 21.7%, 20.8%, 29.6% and 53.8%, respectively, of the biopsies of adjacent normal tissues. Statistical analysis revealed no significant differences. No CRH-R2b transcript was found. Transcript levels of CRH-R1, CRH-R2a, SV1 and pGHRH-R were 0,001023 ± 0,001604, 0,36806255 ± 0,770218392, 1,415537 ± 2,032818 and 4,189554 ± 10, 4429, respectively, in malignant biopsies and 0,000226 ± 0,000376, 0,066274 ± 0,110313, 0,736 ± 1,012704 and 10,12868 ± 19,53721, respectively, in the biopsies of adjacent normal tissues. Statistical analysis revealed no significant differences. Also, there was no significant difference between the expression of CRH-R1 and CRH-R2a, and between the SV1 and pGHRH in malignant tissues. Immunohistochemistry revealed that the two CRH receptor proteins presented distinct distributions, being expressed by other cellular types within the breast tumor. Correlation analysis between the receptors expression and the transcript levels with demographic and clinical characteristics of patients and with the histopathological characteristics of the tumors, showed a negative correlation between the transcript levels of CRH-R1 and the number of full-term pregnancies and between the expression of CRH-R2a and the age of menopause, and a positive correlation between the transcript levels of CRH-R2a and the age of menarche and between the transcript levels of SV1 and the height. Moreover, it was found that the transcript levels of CRH-R1 was negatively related to the expression of pGHRH-R, while the transcript levels of CRH-R2a was positively correlated with the transcript levels of the SV1. Statistical analysis between the expression of the receptors and the time of recurrence of the disease or the survival of the patients revealed no significant differences. Conclusion: All the receptors were found in breast cancer and the respective benign adjacent tissue at similar gene transcript levels. Receptors expression did not correlate to any of the characteristics of the tumor or the patient, indicating no diagnostic potential. Further studies are required in order to unfold biological effects mediated by CRH and GHRH receptors in breast cancer and their potential as therapeutic targets.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kaprara, Athina
  • Καπράρα, Αθηνά

Subjects

dc:subject × 13

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/26957

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kaprara, Athina; Καπράρα, Αθηνά. Μελέτη των υποδοχέων διαφόρων ορμονών του υποθαλάμου σε καρκινοπαθείς. Democritus University of Thrace (DUTH), 2012. http://hdl.handle.net/10442/hedi/26957